Salvinorin A pretreatment preserves cerebrovascular autoregulation after brain hypoxicischemic injury via extracellular signal-regulated kinasemitogen-activated protein kinase in piglets.
Cerebral hypoxiaischemia during infant congenital heart surgery is not uncommon and may induce devastating neurologic disabilities persistent over the lifespan. Hypoxiaischemia-induced cerebrovascular dysfunction is thought to be an important contributor to neurological damage. No pharmacological agents have been found to prevent this. Mitogen activated protein kinase (MAPK), including extracellular signal regulated kinase (ERK), c-Jun-N-terminal kinase, and p38, is thought to contribute to ischemic preconditioning. We investigated whether pretreatment with salvinorin A, the only natural nonopioid κ receptor agonist, could preserve autoregulation of the pial artery via MAPK. The response of the pial artery to hypotension and hypercapnia was monitored in piglets equipped with a closed cranial window before and after hypoxia and ischemia in the presence or absence of U0126, an inhibitor for the protein kinase upstream of ERK, sp600125, an inhibitor of c-Jun-N-terminal kinase or sb203580, an inhibitor of p38. Salvinorin A (10 μgkg IV) was administered 30 minutes before hypoxiaischemia in salvinorin-treated animals. Cerebrospinal fluid samples were collected before and 30 minutes after salvinorin A administration for the measurement of MAPK. Data (n 5) were analyzed by repeated-measures analysis of variance. Pial artery dilation to hypercapnia and hypotension was blunted after hypoxia ischemia but preserved well by pretreatment with salvinorin A. U0126, but not sp600125 or sb203580, abolished the preservative effects of salvinorin A on cerebral vascular autoregulation to hypotension and hypercapnia. The ratio of pERKERK in cerebrospinal fluid increased significantly in salvinorin-treated animals, which was inhibited by U0126. Salvinorin A pretreatment preserves autoregulation of the pial artery to hypotension and hypercapnia after hypoxiaischemia via ERK in a piglet model.